Simulator helps sponsors to assess arrhythmia risk before a candidate enters clinical trials; determine safe drug doses for specific patient populations ST. LOUIS, Aug 01, 2013 (BUSINESS WIRE) -- ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results